CAS 1798033-44-9

Ziprasidone amino acid sodium salt

CAS : 1798033-44-9

Ziprasidone amino acid sodium salt is a kinase inhibitor that has shown potential in the treatment of various cancers. It has been shown to inhibit the activity of human and Chinese hamster kinases, as well as trypsin and tumor cell growth. Ziprasidone amino acid sodium salt has also been found to induce apoptosis in cancer cells, making it a promising candidate for cancer therapy. In addition, this compound has been studied for its potential use as an inhibitor of methotrexate analog uptake in urine, which could be useful in treating certain types of cancer. Furthermore, Ziprasidone amino acid sodium salt has also been investigated for its potential use in the treatment of osteoporosis, as it is an inhibitor of teriparatide-induced bone resorption. Overall, this compound shows great promise as a potential therapeutic agent for various diseases and conditions.

Formule : C₆H₁₃NO

Degré de pureté : Min. 95%

Masse moléculaire : 115.17 g/mol

Ref: 3D-YWC03344

Ziprasidone Amino Acid Sodium Salt(Ziprasidone Impurity C)

Produit contrôlé

CAS : 1798033-44-9

Impurity Ziprasidone EP Impurity C
Stability Very Hygroscopic
Applications Ziprasidone Amino Acid Sodium Salt (Ziprasidone EP Impurity C) is Ziprasidone (Z485000) impurity C.

Formule : C₂₁H₂₂ClN₄NaO₂S

Couleur et forme : Neat

Masse moléculaire : 452.93

Ref: TR-Z484995